Carcinoma, Non-Small Cell

Also known as: Non-small Cell Carcinoma / Non-small cell carcinoma (morphologic abnormality)

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB17146	Abequolixron	1	Recruiting	1
DB11967	Binimetinib	1	Recruiting	1
DB00958	Carboplatin	1	Recruiting	1
DB11963	Dacomitinib	1	Completed	1
DB01248	Docetaxel	1	Recruiting	1
DB00441	Gemcitabine	1	Terminated	1
DB06186	Ipilimumab	1	Recruiting	1
DB01229	Paclitaxel	1	Terminated	1
DB09037	Pembrolizumab	1	Recruiting	2
DB09037	Pembrolizumab	1	Terminated	1
DB00642	Pemetrexed	1	Recruiting	1
DB11714	Durvalumab	1 / 2	Not Yet Recruiting	1
DB11595	Atezolizumab	2	Withdrawn	1
DB00958	Carboplatin	2	Active Not Recruiting	1
DB00515	Cisplatin	2	Active Not Recruiting	1
DB11963	Dacomitinib	2	Completed	1
DB01248	Docetaxel	2	Completed	1
DB11714	Durvalumab	2	Active Not Recruiting	1
DB00773	Etoposide	2	Active Not Recruiting	1
DB17506	Etrumadenant	2	Active Not Recruiting	1
DB16479	Inbakicept	2	Withdrawn	1
DB00642	Pemetrexed	2	Active Not Recruiting	1
DB12257	Platinum	2	Recruiting	1
DB05578	Ramucirumab	2	Withdrawn	1
DB17505	Zimberelimab	2	Active Not Recruiting	1
DB00958	Carboplatin	3	Not Yet Recruiting	1
DB09330	Osimertinib	3	Not Yet Recruiting	1
DB00642	Pemetrexed	3	Not Yet Recruiting	1
DB11885	Anlotinib	Not Available	Recruiting	1
DB16747	Penpulimab	Not Available	Recruiting	1